The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus ...

A 3.875-inch crank will clear the block without any issues. The larger 4.00-inch stroke we used does require some small clearances and Palmisano handled that during his mockup phase of the build.

Alpha Cognition Inc. (the "Company" or "Alpha Cognition") today announced three upcoming presentations at the 2025 Alzheimer's Association International Conference (the "AAIC"), taking place July ...

A key focus of the alliance is to find ways to improve the efficacy of T cell therapies against solid tumours, which has been a stumbling block for ... BCMA in phase 1 and another targeting ...

This dramatic reduction was consistent across influenza strains H1N1 and H3N2, as well as herpes viruses HSV-1 and HSV-2. These findings ... gum is moving through Phase I/II clinical trials.

According to AppMagic estimates, CSR 2 has generated ... The update has commenced phase one of the game’s return, dubbed the "technical test." This is the first of three phases on Rainbow Six Mobile’s ...

Stage 1 required more than just fault proofs, including a security council with decentralized governance and reduced Coinbase control. The developers at Coinbase-incubated Ethereum Layer 2 rollup Base ...

to conduct a Phase 1/2 study. OBI plans to enroll patients with advanced solid tumors. This IND clearance represents a significant milestone for OBI-902, bringing forward a potentially best-in-class ...

MetaVia (MTVA) announced positive results from the 4-week multiple ascending dose Part 2 of its Phase 1 clinical trial of DA-1726, a novel, dual oxyntomodulin analog agonist that functions as a ...

Solid Biosciences Inc. announced that it will present data from its Phase 1/2 INSPIRE DUCHENNE trial of SGT-003, a gene therapy candidate for Duchenne muscular dystrophy, at the upcoming American ...

"We are pleased to advance the potential first-in-class clinical combination of IDE397 and Trodelvy into an initial Phase 1/2 expansion in MTAP-deletion UC based on preliminary safety and clinical ...